ArticleThe World Allergy Organization journal2026
Comprehensive proteomic analysis reveals SPRR3 as an early predictive biomarker for postoperative recurrence in pediatric chronic rhinosinusitis with nasal polyps.
Article in The World Allergy Organization journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pediatric chronic rhinosinusitis with nasal polyps (CRSwNP) exhibits a high rate of postoperative recurrence, yet effective molecular predictors remain lacking. This study aims to explore recurrence-associated proteins and evaluate their predictive value. Methods: Proteomic analysis was performed on nasal mucosa from a discovery cohort, with >1 year of follow-up to identify differentially expressed proteins (DEPs) associated with postoperative recurrence. Candidate proteins were validated in an independent cohort using western blotting, immunofluorescence, qRT-PCR, and serum ELISA. Results: In the discovery cohort, 6 pediatric patients suffering postoperative recurrence were classified as rCRSwNP, and 10 as non-rCRSwNP. Proteomic analysis revealed distinct expression patterns among control, non-rCRSwNP, and rCRSwNP groups. Four candidate proteins (CERS4, PLEKHA6, RAB29, SPRR3) were identified by intersecting the top 50 DEPs. SPRR3 and RAB29 were significantly upregulated in rCRSwNP, primarily localized to the nasal epithelium, as confirmed by western blotting and immunofluorescence. qRT-PCR further validated their increase in the recurrence group. Notably, paired tissue samples showed increased SPRR3 expression at revision surgery compared to baseline, and ELISA revealed higher serum SPRR3 levels in recurrent cases, correlating with recurrence risk. ROC and Kaplan-Meier analyses demonstrated potential predictive value for serum SPRR3. Conclusion: Our study identified a recurrence-associated proteomic signature in pediatric CRSwNP, marked by selective epithelial upregulation of SPRR3. Elevated serum SPRR3 was strongly linked to postoperative recurrence risk, supporting its utility as a predictive biomarker for identifying children at higher risk of relapse.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.